Welcome to our dedicated page for Well Health Tech news (Ticker: WHTCF), a resource for investors and traders seeking the latest updates and insights on Well Health Tech stock.
WELL Health Technologies Corp. reports developments across a Canadian outpatient healthcare platform, digital health software and related technology-enabled services. The company operates a large owned clinic network in Canada and reports recurring updates on patient visits, Canadian Patient Services, primary care and specialty care performance, acquisitions, clinic transformation activity and financial results.
WELL’s news also covers WELLSTAR healthcare technology products, including electronic medical records, AI-powered clinical tools, patient engagement, eReferral and IT managed services. Other recurring themes include HEALWELL AI, CYBERWELL cybersecurity services, virtual cardiology through CardiologyNow, partnerships for remote cardiac monitoring, conference participation and financing capacity for the company’s healthcare operations.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) announces plans to acquire a majority controlling interest in HEALWELL AI concurrent with HEALWELL's proposed acquisition of Orion Health on April 1, 2025. Following the exercise of its call right, WELL will hold approximately 37% economic interest and 69% voting interest in HEALWELL on a non-diluted basis.
WELL has exercised all 20.3M share purchase warrants and converted all HEALWELL convertible debentures, acquiring 43.3M additional Class A shares. The company expects HEALWELL to contribute approximately $160 million in revenue with positive Adjusted EBITDA to WELL's consolidated financial statements over the next 12 months.
HEALWELL's acquisition of Orion Health, valued at approximately $175 million, will provide access to Orion's global customer base serving 150 million lives worldwide. Orion Health is expected to generate over $100 million in revenues mostly from subscription licenses and services with strong double-digit Adjusted EBITDA margins.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has announced a delay in filing its 2024 audited annual financial statements beyond the March 31, 2025 deadline. The delay stems from accounting implications related to its subsidiary Circle Medical Technologies, which is under investigation by the U.S. Attorney's Office regarding certain billing practices.
Circle Medical, which contributed a net loss of $1.1 million to WELL's consolidated net income of $16.6 million in 2023 and less than 2.7% to consolidated Adjusted EBITDA, received a request for voluntary production of documents in September 2024. WELL expects to file the required documents by April 15, 2025, and has applied for a management cease trade order during this period.
The company states that the resolution is not expected to materially affect its cash position and confirms it continues to seek strategic alternatives for Circle Medical.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) reports significant growth in its Canadian operations as of March 4, 2025. The company has added 11 clinics to its Canadian network since February 1, 2025 (9 acquired, 2 absorbed), generating combined revenues of approximately $29 million with $2 million in EBITDA.
Key highlights include:
- 24% organic growth in Canadian clinics for 2024 (12% same-clinic revenue growth, 12% organic absorption)
- Record pipeline of ~70 public sector opportunities across Canada worth over $300 million
- 34 potential clinic acquisition opportunities generating $450 million in revenues
The company is benefiting from increased 'Buy Canadian' sentiment following new procurement policies, particularly in British Columbia, where Premier David Eby announced a ban on new U.S. procurement contracts in response to U.S. tariffs. WELL reports no exposure to these tariffs, with over 60% of its revenues, Adj. EBITDA, and cashflow generated in U.S. dollars.
WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) has announced significant updates for its subsidiary WELLSTAR Technologies Corp. The company has appointed Sarah Xu as VP of Growth Operations and Frank Seiferth as VP of Product, both bringing extensive experience from companies like Google and BlueDot.
WELLSTAR has completed two strategic acquisitions: Microquest, a leading EMR provider serving 375 clinics and 1,600 providers in Alberta, and Bluebird iT, Canada's largest provider of IT solutions for outpatient healthcare clinics, supporting over 700 medical clinics and hospitals. WELL has acquired a 51% stake in Bluebird iT.
With these acquisitions, WELLSTAR now delivers technology solutions to over 40% of all physicians in Canada through its 330+ team members. The company offers solutions including provincially integrated EMRs, revenue optimization, patient engagement solutions, and AI-enabled automation tools.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has released performance metrics for its acquired Canadian clinics, showing strong ROIC figures of 41%, 24%, and 28% for clinics acquired in 2022, 2023, and 2024 respectively, with effective multiples of 2.0x, 2.3x, and 2.6x Adj. EBITDA.
The company's M&A pipeline includes 165 clinics generating over $440 million in annual revenue, with 19 signed LOIs representing approximately $50 million in revenue. Both pipelines maintain double-digit Adj. EBITDA margins.
WELL confirmed it has no exposure to U.S.-Canada tariffs as it doesn't engage in cross-border sales. Over 60% of its revenues, Adj. EBITDA and cashflow is generated in U.S. dollars through U.S.-based entities. The company maintains its long-term goal of reaching $4 billion in revenues from Canadian sources.
WELL Health Technologies has completed seven acquisitions since December 2024, adding approximately $100M in annualized revenue. The acquisitions, paid entirely in cash with no share issuance, span across Canadian Clinics, WELLSTAR, and WELL USA business units. The deals include one of Canada's largest physician recruitment firms, two Canadian Primary Care Clinics, a Provider Staffing acquisition in the US under CRH, two WELLSTAR acquisitions, and Jack Nathan Health.
The company added 75 new clinical assets to its Canadian business, including 72 clinics through the Jack Nathan Health acquisition. WELL's current M&A pipeline includes twelve LOIs reflecting approximately $65M in revenues, with all but two targets based in Canada. The company maintains EBITDA margins in line with its 2024 guidance, and its post-deal leverage ratio remains below the level reported in Q3 2024.
WELL Health Technologies has completed the acquisition of Jack Nathan Medical's Canadian clinical assets, including 13 owned and operated clinics generating over $9M in revenue, and 59 licensee clinics contributing $2.2M in annual high-margin revenue. The owned clinics are expected to be EBITDA-positive within 12 months. Through agreements with Walmart Canada, WELL gains potential expansion opportunities across Walmart's 400+ locations. The acquired clinics will be rebranded as WELL Health Medical Centres, incorporating WELL's tech-enabled healthcare approach. The licensee clinics will form WELL's new 'Affiliate Clinic' business model, allowing healthcare providers to operate independently while leveraging WELL's infrastructure.
WELL Health Technologies achieved record Q3-2024 results with revenue of $251.7M, up 27% YoY, driven by 23% organic growth. The company reached a $1B annualized revenue run-rate ahead of schedule and posted record Adjusted EBITDA of $32.7M, up 16% YoY. Total patient visits increased 41% to 1.5M. Based on strong performance, WELL raised its 2024 revenue guidance to $985-995M while maintaining Adjusted EBITDA guidance in the upper half of $125-130M range. The company's Canadian Patient Services grew 35% YoY, while US operations Wisp and Circle Medical showed strong growth of 35% and 61% respectively.
WELL Health Technologies has announced the acquisition of Jack Nathan Medical's Canadian clinical assets, including 16 owned and operated clinics generating over $10 million in revenue, and 62 licensee clinics contributing $2.2 million in annual revenue. The deal includes rights to operate medical clinics in Walmart Canada stores, providing access to over 400 potential locations. The owned clinics are expected to be profitable on an adjusted EBITDA basis by 2025. The acquisition introduces WELL's new 'Affiliate Clinic' business model, where physicians own and operate smaller clinics with WELL's technology support.
WELL Health Technologies and HEALWELL AI have expanded their multi-year strategic alliance to launch and manage clinical trial sites across WELL's network of over 180 Canadian clinics. The partnership combines WELL's healthcare infrastructure with HEALWELL's AI technology and Contract Research Organization capabilities to create an end-to-end clinical trials service. The collaboration will leverage WELL's extensive network of primary and specialty care clinics, including diagnostic centers specializing in cardiology, radiology, sleep medicine, and endocrinology, to enhance patient recruitment and trial execution while opening new revenue streams.